Want to see AU:AHC full AI Analyst Report?
Top Page
Austco Healthcare Limited
(Sydney:AHC)
Select Model
Select Model
Rating:71Outperform
Price Target:
AU$0.30
▲(35.45% Upside)
Action:Upgraded
Date:08/29/26
The score is driven primarily by strong financial performance (fast growth, improving earnings, and low leverage), tempered by margin volatility and less consistent cash-flow trends. Valuation is supportive with a low P/E, while technicals are mixed with short-term strength but a weaker longer-term trend.
Positive Factors
Strong Revenue Growth
Rapid multi-year revenue expansion indicates stronger market activity and growing adoption of Austco’s healthcare communication and workflow solutions. If sustained, this scale can improve operating leverage, support investment in products and service capability, and strengthen the company’s competitive position.
Negative Factors
Gross Margin Compression
The sharp gross-margin decline raises questions about the durability of recent revenue growth and the profitability of the underlying sales mix. If weaker margins persist, Austco may need stronger pricing, delivery efficiency or product mix to convert expansion into proportionate operating earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Rapid multi-year revenue expansion indicates stronger market activity and growing adoption of Austco’s healthcare communication and workflow solutions. If sustained, this scale can improve operating leverage, support investment in products and service capability, and strengthen the company’s competitive position.
Read all positive factors
Austco Healthcare Limited (AHC) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$101.18M
Dividend Yield3.96%
Average Volume (3M)196.25K
Price to Earnings (P/E)11.2
Beta (1Y)0.74
Revenue Growth15.77%
EPS Growth48.47%
CountryAU
Employees102
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)0.02
Shares Outstanding374,751,280
10 Day Avg. Volume332,408
30 Day Avg. Volume196,255
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.50
Price to Sales (P/S)0.99
P/FCF Ratio7.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.45Price Target Upside104.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.03
Revenue Forecast (FY)AU$100.00M
Austco Healthcare Limited Business Overview & Revenue Model
Company Description
Austco Healthcare Limited, through its subsidiaries, operates as a global entity focused on the development, production, and comprehensive servicing of advanced healthcare and electronic communication systems. The company's market reach extends ac...
How the Company Makes Money
null...
Austco Healthcare Limited Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
86
Very Positive
Cash Flow
62
Positive
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 94.24M | 81.41M | 58.15M | 41.98M | 35.88M |
| Gross Profit | 20.96M | 42.37M | 30.67M | 6.68M | 18.85M |
| EBITDA | 14.80M | 11.10M | 8.11M | 3.60M | 3.73M |
| Net Income | 9.01M | 5.93M | 7.08M | 2.26M | 2.33M |
Balance Sheet | |||||
| Total Assets | 88.50M | 91.07M | 68.70M | 37.85M | 34.03M |
| Cash, Cash Equivalents and Short-Term Investments | 16.28M | 14.48M | 13.56M | 4.67M | 7.63M |
| Total Debt | 3.95M | 3.88M | 1.78M | 524.00K | 979.00K |
| Total Liabilities | 26.38M | 39.34M | 24.33M | 12.85M | 10.94M |
| Stockholders Equity | 62.12M | 51.73M | 44.38M | 25.00M | 23.09M |
Cash Flow | |||||
| Free Cash Flow | 11.72M | 10.66M | 7.45M | -1.25M | 315.00K |
| Operating Cash Flow | 12.51M | 13.42M | 11.35M | 320.00K | 1.94M |
| Investing Cash Flow | -8.82M | -12.32M | -11.06M | -1.57M | -1.63M |
| Financing Cash Flow | -1.43M | -402.00K | 8.84M | -1.58M | -312.00K |
Austco Healthcare Limited Technical Analysis
Positive
0.22
Price Trends
0.23
Positive
0.26
Positive
0.32
Negative
Market Momentum
<0.01
Negative
68.85
Neutral
80.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHC, the sentiment is Positive. The current price of 0.22 is below the 20-day moving average (MA) of 0.23, below the 50-day MA of 0.23, and below the 200-day MA of 0.32, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 68.85 is Neutral, neither overbought nor oversold. The STOCH value of 80.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:AHC.
Austco Healthcare Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | AU$101.18M | 11.16 | 14.90% | 3.96% | 15.77% | 48.47% | |
61 Neutral | AU$141.73M | 61.76 | 2.53% | ― | 26.61% | 41.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$163.64M | -9.45 | -203.69% | ― | -1.53% | 28.29% | |
50 Neutral | AU$231.74M | -14.58 | -5.34% | 2.79% | 1.84% | -178.23% | |
49 Neutral | AU$35.44M | -1.91 | -58.13% | ― | 2.08% | -195.31% | |
47 Neutral | AU$65.80M | -7.37 | -24.29% | ― | -17.35% | -47.29% |
* Healthcare Sector Average
AU:AHC
Austco Healthcare Limited
0.27
-0.10
-27.03%
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
0.20
-0.04
-17.02%
AU:M7T
Mach7 Technologies
0.28
-0.03
-11.11%
AU:PGC
Paragon Care Limited
0.14
-0.19
-57.58%
AU:BMT
Beamtree Holdings Ltd
0.12
-0.11
-47.83%
AU:ALC
Alcidion Group Limited
0.11
0.02
16.67%
Austco Healthcare Limited Corporate Events
Austco Healthcare Delivers Record Revenue and Margin Gains in FY26
Aug 27, 2026
Austco Healthcare reported record FY26 customer revenue of $94.2 million, up 16% year on year, with EBITDA rising 14% to $14.9 million and NPAT surging 52% to $9.0 million, supported by a $51.2 million pipeline of unfilled contracted revenue. Perf...
Austco Healthcare Profit Jumps 52% on Strong Revenue Growth
Aug 27, 2026
Austco Healthcare Limited reported a 15.8% rise in revenue to $94.2 million for the year ended 30 June 2026, with EBITDA up 14.0% to $14.8 million and EBIT rising 7.0% to $10.9 million. Net profit after tax surged 51.8% to $9.0 million, supported ...
Austco Healthcare strengthens South Australian presence with MCS acquisition
Aug 13, 2026
Austco Healthcare Limited has completed the acquisition of Medical Communications Systems, its long-standing certified nurse call reseller in South Australia, bringing the reseller in-house after a relationship dating back to 2011. MCS, which has ...
Austco Healthcare buys South Australian reseller in earnings-accretive deal
Aug 9, 2026
Austco Healthcare has agreed to acquire 100% of Medical Communications Systems, its long-standing certified nurse call reseller in South Australia, bringing the operation in-house. The deal continues Austco’s reseller acquisition strategy an...
Austco Wins A$4.2m, 10-Year Maintenance Deal at Singapore’s Jurong Health Complex
Jul 23, 2026
Austco Healthcare has secured a ten-year maintenance contract worth about A$4.2 million for its Tacera Clinical Care Communications solution at Singapore’s Jurong Health Complex, covering Ng Teng Fong General Hospital and Jurong Community Ho...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.